MIT researchers have created an inexpensive method to screen for millions of different biomolecules (DNA, proteins, etc.) in a single sample--a technology that could make possible the development of low-cost clinical bedside diagnostics.
MIT researchers have created an inexpensive method to screen for millions of different biomolecules (DNA, proteins, etc.) in a single sample--a technology that could make possible the development of low-cost clinical bedside diagnostics.